Exor N.V. Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001589122
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2023 · 6 positions · Total reported value $30.21B · Top-10 concentration 100.0% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 42.9% · 3 new · 0 cut · 0 exited
Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking
In its Q4 2023 13F filing, Exor N.V. disclosed 6 equity positions with a combined reported value of $30.21B. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Large / Focused / Industrials Tilt / High Turnover.
The largest disclosed positions as of Q4 2023 were RACE ($15.04B), STLA ($10.48B), CNH ($4.47B). By sector, the heaviest allocations are Industrials 99.3%, Health Care 0.2%.
Versus the prior quarter, Exor N.V. opened 3 new positions, trimmed 0 and fully exited 0, a turnover rate of 42.9% of positions. The portfolio's overlap with the prior quarter was 100% of names.
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
Insider Transactions (Form 4)
Latest Exor N.V. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Exor N.V. is an SEC-registered 13F filer. As of Q2 2026 it reported 3 US equity positions with a combined value of $5.46B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).
Portfolio Structure
- 3 positions · $5.46B reported value (Q2 2026)
- Top 10 holdings = 100.0% of reported value
- Largest position: PHG (KONINKLIJKE PHILIPS N V) at 92.6%
- Average position size: $1.82B
Sector Tilt
- Health Care 92.6%
- Information Technology 7.4%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 1 added
- 2 positions unchanged
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
44.44M | $15.04B | 49.78% | Hold | |
| 2 |
|
449.41M | $10.48B | 34.70% | Hold | |
| 3 |
|
366.93M | $4.47B | 14.79% | Hold | |
| 4 |
|
1.01M | $117.91M | 0.39% | Hold | |
| 5 |
|
4.22M | $71.88M | 0.24% | Hold | |
| 6 |
|
2.50M | $28.93M | 0.10% | Hold |
FAQ
What did Exor N.V. buy in 2023-Q4?
In its 2023-Q4 13F filing, Exor N.V. reported 6 equity positions worth $30.21B in aggregate; its largest disclosed positions were RACE ($15.04B), STLA ($10.48B), CNH ($4.47B).
How large is Exor N.V.'s portfolio?
Exor N.V. reported $30.21B of long equity holdings across 6 positions as of 2023-Q4. Top-10 holdings account for 100.0% of reported value.
What is Exor N.V.'s investment style?
HoldingsHub classifies the portfolio as Large / Focused / Industrials Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.